Correction

Molecular Network Basis of Invasive Pituitary Adenoma: A Review (vol 10, 7, 2019)

FRONTIERS IN ENDOCRINOLOGY (2019)

Journal

FRONTIERS IN ENDOCRINOLOGY

Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA

DOI: 10.3389/fendo.2019.00657

Keywords

angiogenesis; endocrinology; invasiveness; molecular network; pituitary adenoma

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Recommended

Article Clinical Neurology

What is the current clinical practice in pituitary adenoma surgery in Europe? European Pituitary Adenoma Surgery Survey (EU-PASS) results-technical part

Martin Majovsky, Andre Grotenhuis, Nicolas Foroglou, Francesco Zenga, Sebastien Froehlich, Florian Ringel, Nicolas Sampron, Nick Thomas, Martin Komarc, David Netuka

Summary: Pituitary adenoma surgery in European neurosurgical centers shows significant variation in surgical approach, postoperative care, and management of complications. High-volume centers are more proactive in dealing with cerebrospinal fluid leaks, while low-volume centers are less meticulous in sellar closure. Further discussion is needed to address these discrepancies and potentially develop standardized protocols for improved patient outcomes.

NEUROSURGICAL REVIEW (2022)

Add to Collection

Article Neurosciences

SIRT1 Contributes as an Invasiveness Marker in Pituitary Adenoma

Domantas Vaiciulis, Alvita Vilkeviciute, Greta Gedvilaite, Brigita Glebauskiene, Loresa Kriauciuniene, Rasa Liutkeviciene

Summary: The study revealed that SIRT1 rs7895833 G/G genotype is associated with about 13-fold increased odds of active PA development, and SIRT1 serum levels are significantly higher in women with PA compared to healthy women.

BRAIN SCIENCES (2021)

Add to Collection

Article Endocrinology & Metabolism

The prevalence of acromegaly is higher than previously reported: Changes over a three-decade period

Charlotte Aagaard, Amanda S. Christophersen, Susanne Finnerup, Christian Rosendal, Helga A. Gulisano, Kare S. Ettrup, Peter Vestergaard, Jesper Karmisholt, Eigil Husted Nielsen, Jakob Dal

Summary: This study investigated the prevalence and patient characteristics of acromegaly over time, as well as the impact of treatment changes on disease control. The study found that the prevalence of acromegaly has increased significantly, with a shift towards a milder clinical phenotype. Modern treatment approaches enable individualized treatment and disease control in the majority of patients with acromegaly.

CLINICAL ENDOCRINOLOGY (2022)

Add to Collection

Article Clinical Neurology

MEG3/MIR-376B-3P/HMGA2 axis is involved in pituitary tumor invasiveness

Dimin Zhu, Zheng Xiao, Zongming Wang, Bin Hu, Chengbin Duan, Ziyan Zhu, Nailin Gao, Yonghong Zhu, Haijun Wang

Summary: MEG3 and MIR-3768-3P expression levels were found to be decreased in patients with CNFPA, and their excessive expression inhibited tumorigenesis and promoted apoptosis in PDFS cells. MEG3 acted as an enhancer of MIR-3768-3P expression, while HMGA2 served as an oncogene in pituitary adenoma that could be negatively regulated by MEG3 via enriching MIR-3768-3P, revealing a novel regulatory network in CNFPAs.

JOURNAL OF NEUROSURGERY (2021)

Add to Collection

Article Medicine, General & Internal

Prognostic Factors for Invasiveness and Recurrence of Pituitary Adenomas: A Series of 94 Patients

Petros Stefanidis, Georgios Kyriakopoulos, Andreas Miltiadis Seretis, Stefanos Korfias, Stamatios Theocharis, Anna Angelousi

Summary: This study evaluated the expression of Ki-67, CD-56, Cyclin-D1, and E-Cadherin in pituitary adenomas (PAs) and their association with clinical manifestation, tumor size, invasiveness, and risk of recurrence. Cyclin-D1 and Ki-67 were found to be positively correlated with tumor size, recurrence, extension beyond the sellar region, and invasion of the cavernous sinus. However, there was no correlation between CD-56 and E-Cadherin expression and the parameters mentioned above. Cyclin-D1 and Ki-67 may be promising markers in predicting the behavior and recurrence of PAs, but further studies are needed to confirm their role in routine evaluation of PAs.

DIAGNOSTICS (2022)

Add to Collection

Article Medicine, General & Internal

Classifying Pituitary Adenoma Invasiveness Based on Radiological, Surgical and Histological Features: A Retrospective Assessment of 903 Cases

Liang Lu, Xueyan Wan, Yu Xu, Juan Chen, Kai Shu, Ting Lei

Summary: Invasiveness is an important predictor of surgical outcome and long-term prognosis in patients with pituitary adenomas (PAs). This study assessed PA invasiveness through radiological, surgical, and histological perspectives and established a classification scheme to predict invasive behavior and poor prognosis. The study found that radiological and surgical invasiveness were better predictors of complete resection and recurrence/progression-free survival rates than histological invasiveness. Knosp grades with surgical invasiveness were also better predictors of prognosis compared to Knosp grades without surgical invasiveness. The classification schemes developed based on invasiveness and Knosp classification were found to be clinically valuable in predicting prognosis.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Endocrinology & Metabolism

The hallmarks of cancer horizontal ellipsis in pituitary tumors?

Daniel Marrero-Rodriguez, Keiko Taniguchi-Ponciano, Jacobo Kerbel, Amayrani Cano-Zaragoza, Ilan Remba-Shapiro, Gloria Silva-Roman, Sandra Vela-Patino, Sergio Andonegui-Elguera, Alejandra Valenzuela-Perez, Moises Mercado

Summary: This review evaluates the biological processes underlying malignant transformation and their relevance to the development of pituitary adenomas. It addresses various processes such as genome instability, epigenetic reprogramming, angiogenesis, proliferative signals, immune evasion, and inflammation in relation to pituitary tumors. Additionally, it discusses the existence of oncogene-induced senescence in these tumors. Understanding these processes can provide insights into the resistance of pituitary tumors to malignant transformation and contribute to the development of novel anticancer treatments.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2023)

Add to Collection

Article Endocrinology & Metabolism

Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases

Keyi Zhang, Xuefei Shou, Hong Chen, Nidan Qiao, Wenqiang He, Zhengyuan Chen, Ming Shen, Shiqi Li, Yao Zhao, Zhaoyun Zhang, Yiming Li, Hongying Ye, Yongfei Wang

Summary: The study investigated the clinical characteristics of SCAs with positive and negative ACTH immunostaining, finding that ACTH-negative SCAs were more clinically silent and more likely to demonstrate multiple microcysts on MRI. The prevalence of SCAs, especially ACTH-negative SCAs, was substantially underestimated and should be given enough attention due to the high aggressiveness of this subtype of refractory pituitary adenoma.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Using Molecular Imaging to Enhance Decision Making in the Management of Pituitary Adenomas

Waiel A. Bashari, Russell Senanayake, James MacFarlane, Daniel Gillett, Andrew S. Powlson, Angelos Kolias, Richard J. Mannion, Olympia Koulouri, Mark Gurnell

Summary: For most patients with suspected or confirmed pituitary adenomas, MRI is usually sufficient for clinical decision making, but additional MR sequences may be needed for certain patients. There is a subgroup of patients for whom MRI cannot accurately localize the tumor site, leading to limited intervention options. Emerging evidence suggests that hybrid imaging, combining molecular and cross-sectional modalities, can improve tumor detection and localization for targeted intervention, potentially reducing the need for long-term high-cost therapies.

JOURNAL OF NUCLEAR MEDICINE (2021)

Add to Collection

Article Veterinary Sciences

Challenges of transsphenoidal pituitary surgery in severe brachycephalic dogs

Lucinda L. Van Stee, Sarah J. Van Rijn, Sara Galac, Bjorn P. Meij

Summary: This study describes the challenges in approaching the sphenoid bone and localizing the correct burr hole site in severe brachycephalic dogs undergoing transsphenoidal hypophysectomy. Meticulous presurgical planning and extension of the approach into the caudal hard palate were necessary for successful surgery. Despite the technical difficulties, good outcomes were achieved.

FRONTIERS IN VETERINARY SCIENCE (2023)

Add to Collection

Article Medicine, General & Internal

Incidentally detected acromegaly: single-center study of surgically treated patients over 22 years

Erica Alexandra Giraldi, Emir Veledar, Nelson M. Oyesiku, Adriana G. Ioachimescu

Summary: In recent years, an increased number of patients with GH-secreting adenomas were incidentally detected (ID). The ID group and CP group showed differences in clinical, biochemical, and radiological characteristics, but had similar 3-month biochemical remission rates and rates of normal IGF-1 levels after surgery.

JOURNAL OF INVESTIGATIVE MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Socioeconomic predictors of case presentations and outcomes in 225 nonfunctional pituitary adenoma resections

Robert C. Osorio, Matheus P. Pereira, Rushikesh S. Joshi, Kevin C. Donohue, Patricia Sneed, Steve Braunstein, Philip Theodosopoulos, Ivan H. El-Sayed, Jose Gurrola, Sandeep Kunwar, Lewis S. Blevins, Manish K. Aghi

Summary: This study examined the influence of socioeconomic status (SES) on the clinical presentations and outcomes of nonfunctional pituitary adenoma (NFPA) resections. The presence of a primary care provider (PCP) was found to be the most important factor, affecting hospital lengths of stay, readmission rates, follow-up adherence, and tumor recurrence.

JOURNAL OF NEUROSURGERY (2022)

Add to Collection

Review Endocrinology & Metabolism

Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors

Antonio Bianchi, Sabrina Chiloiro, Antonella Giampietro, Simona Gaudino, Rosalinda Calandrelli, Ciro Mazzarella, Carmelo Caldarella, Mario Rigante, Marco Gessi, Liverana Lauretti, Laura De Marinis, Alessandro Olivi, Alfredo Pontecorvi, Francesco Doglietto

Summary: Growth hormone-secreting adenomas exhibit a wide range of behaviors and outcomes, from mild disease to aggressive neoplasms. Treatment for patients who do not respond to surgery or first-generation somatostatin receptor ligands may involve multiple surgical, medical, and radiation treatments. Currently, there are no markers that can predict the prognosis or aggressiveness of acromegaly. A multidisciplinary approach is necessary to tailor treatment for difficult/aggressive cases, including radiation therapy, chemotherapy, and emerging treatments.

FRONTIERS IN ENDOCRINOLOGY (2023)

Add to Collection

Article Endocrinology & Metabolism

The Upregulation of Molecules Related to Tumor Immune Escape in Human Pituitary Adenomas

Zhiyu Xi, Pamela S. Jones, Masaaki Mikamoto, Xiaobin Jiang, Alexander T. Faje, Chuansheng Nie, Kathryn E. Labelle, Yunli Zhou, Karen K. Miller, Roy J. Soberman, Xun Zhang

Summary: Aggressive pituitary adenomas have increased expression of PD-L2, CD80, and CD86 compared to normal pituitary glands, and significantly higher levels of CD80 and CD86 compared to non-aggressive tumors. These findings support further research on the potential role of immune checkpoint inhibition therapy in the treatment of pituitary adenomas.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Article Clinical Neurology

Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence

Ben A. Strickland, Shane Shahrestani, Robert G. Briggs, Anna Jackanich, Sherwin Tavakol, Kyle Hurth, Mark S. Shiroishi, Chia-Shang J. Liu, John D. Carmichael, Martin Weiss, Gabriel Zada

Summary: SCAs are a subtype of NFAs that are more biologically aggressive, with patients presenting with more cranial neuropathy and headaches, and a shorter progression-free survival duration.

JOURNAL OF NEUROSURGERY (2021)

Add to Collection

Review Endocrinology & Metabolism

Molecular Network Basis of Invasive Pituitary Adenoma: A Review

Qi Yang, Xuejun Li

FRONTIERS IN ENDOCRINOLOGY (2019)

Add to Collection

Review Biochemistry & Molecular Biology

PTTG has a Dual Role of Promotion-Inhibition in the Development of Pituitary Adenomas

Zujian Xiong, Xuejun Li, Qi Yang

PROTEIN AND PEPTIDE LETTERS (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems

Hang Cao, Xuejun Li, Feiyifan Wang, Yueqi Zhang, Yi Xiong, Qi Yang

CURRENT MEDICINAL CHEMISTRY (2020)

Add to Collection

Article Neurosciences

Effect of intra- and inter-tumoral heterogeneity on molecular characteristics of primary IDH-wild type glioblastoma revealed by single-cell analysis

Zujian Xiong, Qi Yang, Xuejun Li

CNS NEUROSCIENCE & THERAPEUTICS (2020)

Add to Collection

Article Cell Biology

Single-cell RNA-Seq reveals transcriptional heterogeneity and immune subtypes associated with disease activity in human myasthenia gravis

Wanlin Jin, Qi Yang, Yuyao Peng, Chengkai Yan, Yi Li, Zhaohui Luo, Bo Xiao, Liqun Xu, Huan Yang

Summary: This study used single-cell sequencing to reveal the transcriptomes of individual cells in patients with myasthenia gravis, identifying 13 major cell clusters and 39 cell subgroups. It was found that B cells, CD4(+) T cells, and monocytes showed more heterogeneity in MG patients, with expanded CD4(+) T cells. Further analyses showed that B cells in MG exhibited higher activity towards plasma cell differentiation, CD4(+) T cell subsets were unbalanced, and monocytes showed highly activated inflammatory pathways. Additionally, a disease-relevant subgroup of CD180(-) B cells was discovered, which was associated with disease activity and anti-AChR antibody levels in MG patients.

CELL DISCOVERY (2021)

Add to Collection

Article Surgery

Multivariate Analysis and Validation of the Prognostic Factors for Skull Base Chordoma

Chubei Teng, Qi Yang, Zujian Xiong, Ningrong Ye, Xuejun Li

Summary: The study identified age, tumor size, surgery, primary site, and tumor stage as main factors affecting the prognosis of skull base chordoma. Resection of the tumor as much as possible while ensuring safety, combined with postoperative radiotherapy may be the optimum treatment for skull base chordoma.

FRONTIERS IN SURGERY (2021)

Add to Collection

Article Oncology

Deep Learning Model for Intracranial Hemangiopericytoma and Meningioma Classification

Ziyan Chen, Ningrong Ye, Nian Jiang, Qi Yang, Siyi Wanggou, Xuejun Li

Summary: Our study found that SFT/HPC showed more invasion to venous sinus (p = 0.001), more cystic components (p < 0.001), and more heterogeneous enhancement patterns (p < 0.001). The deep learning model achieved a high classification accuracy of 0.889 with an AUC of 0.91 in the validation set. Feature maps demonstrated distinct clustering of SFT/HPC and meningioma in the training and test cohorts, and the attention of the deep learning model mainly focused on the tumor bulks representing the solid texture features for discrimination.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Oncology

Classification of Gliomas and Germinomas of the Basal Ganglia by Transfer Learning

Ningrong Ye, Qi Yang, Ziyan Chen, Chubei Teng, Peikun Liu, Xi Liu, Yi Xiong, Xuelei Lin, Shouwei Li, Xuejun Li

Summary: “By using a transfer learning model based on the T1C sequence, germinomas and gliomas of the basal ganglia can be accurately distinguished preoperatively.”

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Neurosciences

Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity

Xin Chen, Ali Momin, Siyi Wanggou, Xian Wang, Hyun-Kee Min, Wenkun Dou, Zheyuan Gong, Jade Chan, Weifan Dong, Jerry J. Fan, Yi Xiong, Kamilia Talipova, Hongyu Zhao, Yuki X. Chen, Kelly Veerasammy, Adam Fekete, Sachin A. Kumar, Hongwei Liu, Qi Yang, Joe Eun Son, Zhengchao Dou, Malini Hu, Parnian Pardis, Kyle Juraschka, Laura K. Donovan, Jiao Zhang, Vijay Ramaswamy, Hayden J. Selvadurai, Peter B. Dirks, Michael D. Taylor, Lu-Yang Wang, Chi-chung Hui, Rinat Abzalimov, Ye He, Yu Sun, Xuejun Li, Xi Huang

Summary: The major obstacles in brain cancer treatment, including the blood-tumor barrier (BTB) and quiescent tumor cells, have been addressed in this study. Sox2+ tumor cells in mouse medulloblastoma (MB) project cellular processes to ensheathe capillaries, which depend on the mechanosensitive ion channel Piezo2. Targeting Piezo2 not only compromises the BTB and reduces the quiescence of tumor cells, but also enhances the response to chemotherapy, improving the treatment outcome for brain cancer patients.

NEURON (2023)

Add to Collection

Article Biology

A comprehensive machine-learning model applied to MRI to classify germinomas of the pineal region

Ningrong Ye, Qi Yang, Peikun Liu, Ziyan Chen, Xuejun Li

Summary: In this study, a computational framework was used to predict the histology of pineal region tumors based on radiomics features and demographics. The models that combined demographics and radiomics features performed the best, with an AUC of 0.88. T1 and T2 sequences were found to be the most informative for differentiating pineal tumors.

COMPUTERS IN BIOLOGY AND MEDICINE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Alterations in 3D chromatin organization contribute to tumorigenesis of EGFR-amplified glioblastoma

Qi Yang, Nian Jiang, Han Zou, Xuning Fan, Tao Liu, Xi Huang, Siyi Wanggou, Xuejun Li

Summary: In this study, the alterations in 3D chromatin organization of EGFR-amplified glioblastoma were explored, and it was found that the chromatin relaxation and unexpected entanglement of chromosome regions were observed in the glioblastoma cells. The activation of compartments reshaped chromatin accessibility and activated tumorigenesis-related genes. The altered topological associating domains (TADs) and chromatin loop alterations were associated with oncogene activation and tumor repressor deactivation.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)

Add to Collection

Article Oncology

Systematic Analysis of 4-gene Prognostic Signature in Patients with Diffuse Gliomas Based on Gene Expression Profiles

Chunhai Huang, Zujian Xiong, Qi Yang, Xuejun Li

Summary: The study identified 67 genes associated with malignant progression of diffuse glioma using WGCNA method and established a 4-gene molecular marker including KDELR2, EMP3, TIMP1, and TAGLN2. The molecular marker served as an independent predictor of prognosis in patients with diffuse gliomas, showing good predictive power and associations with clinical and genetic backgrounds of gliomas.

JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Integrating Genomic Data with Transcriptomic Data for Improved Survival Prediction for Adult Diffuse Glioma

Qi Yang, Yi Xiong, Nian Jiang, Fanyuan Zeng, Chunhai Huang, Xuejun Li

JOURNAL OF CANCER (2020)

Add to Collection

Article Oncology

Improved Prognostic Prediction of Glioblastoma using a PAS Detected from Single-cell RNA-seq

Hongwei Liu, Qi Yang, Yi Xiong, Zujian Xiong, Xuejun Li

JOURNAL OF CANCER (2020)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.